Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Wellness
Home & Realty
Outdoor Guide
Women
Class of 2023
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2023 Readersâ Choice Winners
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by ADMA Biologics, Inc.
ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update
August 09, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023
August 02, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA
July 19, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update
May 10, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023
May 03, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Amendment to Credit Agreement
May 02, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 23, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023
March 16, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA
February 08, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance
January 17, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces FDA Approval for Room Temperature Storage of ASCENIV™ & BIVIGAM®
December 13, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
December 09, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock
December 07, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Proposed Public Offering of Common Stock
December 06, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Preliminary Fourth Quarter 2022 Revenue Estimate
December 06, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Third Quarter 2022 Financial Results and Provides Business Update
November 09, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Report Third Quarter 2022 Financial Results on November 9, 2022
November 02, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA BioCenters Receives FDA Approval for its Seventh Plasma Collection Center, Located in Greensboro, NC
October 31, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.